These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15272207)

  • 1. Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
    Kyoi T; Kitazawa S; Tajima K; Zhang X; Ukai Y
    J Pharmacol Sci; 2004 Jul; 95(3):321-8. PubMed ID: 15272207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
    Zhang X; Tajima K; Kageyama K; Kyoi T
    World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats.
    Ohba R; Otaka M; Odashima M; Jin M; Komatsu K; Konishi N; Wada I; Horikawa Y; Matsuhashi T; Oyake J; Hatakeyama N; Watanabe S
    J Gastroenterol; 2006 Jan; 41(1):34-40. PubMed ID: 16501855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
    Kyoi T; Noda K; Oka M; Ukai Y
    Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivo.
    Tofovic SP; Zacharia LC; Carcillo JA; Jackson EK
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):787-92. PubMed ID: 11022970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
    Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M; Martin-Chouly CA; Brinchault G; Leportier-Comoy C; Depincé A; Bertrand C; Lagente V; Belleguic C; Pruniaux MP
    Pulm Pharmacol Ther; 2005; 18(1):49-54. PubMed ID: 15607127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats.
    Takagi T; Naito Y; Ichikawa H; Tomatsuri N; Katada K; Isozaki Y; Kuroda M; Kokura S; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):376-81. PubMed ID: 15720836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats.
    Ichikawa H; Naito Y; Takagi T; Tomatsuri N; Yoshida N; Yoshikawa T
    Redox Rep; 2002; 7(5):343-6. PubMed ID: 12688526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of gastric mucosal inflammation induced by aspirin through inhibition of selective type III phospshodiesterase in rats.
    Odashima M; Otaka M; Ohba R; Jin M; Wada I; Horikawa Y; Matsuhashi T; Hatakeyama N; Oyake J; Watanabe S
    Dig Dis Sci; 2007 May; 52(5):1355-9. PubMed ID: 17372821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates aspirin-induced gastric mucosal injury in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Konishi N; Wada I; Horikawa Y; Matsuhashi T; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    Dig Dis Sci; 2005 Jun; 50(6):1097-102. PubMed ID: 15986861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone: Novel gastroprotective mechanisms.
    Magdy MA; Hanan el-A; Nabila el-M
    Eur J Pharmacol; 2012 Dec; 697(1-3):126-31. PubMed ID: 23051678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin protects against gastric ischemia-reperfusion injury in rats.
    De La Lastra CA; Cabeza J; Motilva V; Martin MJ
    J Pineal Res; 1997 Sep; 23(2):47-52. PubMed ID: 9392441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
    Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4.
    Kleinman EF; Campbell E; Giordano LA; Cohan VL; Jenkinson TH; Cheng JB; Shirley JT; Pettipher ER; Salter ED; Hibbs TA; DiCapua FM; Bordner J
    J Med Chem; 1998 Jan; 41(3):266-70. PubMed ID: 9464356
    [No Abstract]   [Full Text] [Related]  

  • 20. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.
    Knapp CM; Foye MM; Ciraulo DA; Kornetsky C
    Pharmacol Biochem Behav; 1999 Jan; 62(1):151-8. PubMed ID: 9972858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.